Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Journal of Clinical Immunology
Literature
1.
O’connell TX, Horita TJ, Kasravi B. Understanding and interpreting serum protein electrophoresis the pattern of serum protein electrophoresis results depends on the fractions of two major types of protein: albumin and globulins. 2005.
2.
Karafin MS, Humphrey RL, Detrick B. Evaluation of monoclonal and oligoclonal gammopathies in a pediatric population in a major urban center. Am J Clin Pathol. 2014;141:482–7.CrossRefPubMed
3.
Dalloz JC, Castaing N, Nezelof C, Seligmann M. Paraproteinémie transitoire de type gamma. Presse Med. 1965;73:1541–6.PubMed
4.
Rádl J, Masopust J, Houštěk J, Hrodek O. Paraproteinaemia and unusual dys-γ-globulinaemia in a case of Wiskott-Aldrich syndrome. An immunochemical study. Arch Dis Child. 1967;42:608–14.CrossRefPubMedPubMedCentral
5.
Blaese RM, Strober W, Levy AL, Waldmann TA. Hypercatabolism of IgG, IgA, IgM, and albumin in the Wiskott-Aldrich syndrome. J Clin Invest. 1971;50:2331–8.CrossRefPubMedPubMedCentral
6.
7.
Bruce RM, Blaese RM. Monoclonal gammopathy in the Wiskott-Aldrich syndrome. J Pediatr. 1974;85:204–7.CrossRefPubMed
8.
Radl J, Dooren LJ, Morell A, Skvaril F, Vossen JMJJ, Uittenbogaart CH. Immunoglobulins and transient paraproteins in sera of patients with the Wiskott-Aldrich syndrome: a follow-up study. Clin Exp Immunol. 1976;25:256–63.PubMedPubMedCentral
9.
Yoshida K, Minegishi Y, Okawa H, Yata J, Tokoi S, Kitagawa T, et al. Epstein-Barr virus-associated malignant lymphoma with macroamylasemia and monoclonal gammopathy in a patient with Wiskott-Aldrich syndrome. Pediatr Hematol Oncol. 1997;14:85–9.CrossRefPubMed
10.
Simão I, Cordeiro AI, Borrego LM, Martins C, Neves C, Neves JF. Monoclonal IgG kappa gammopathy previous to hematopoietic stem cell transplantation in an infant with severe combined immunodeficiency. Clin Immunol. 2012;145:133–5.CrossRefPubMed
11.
Atkin C, Richter A, Sapey E. What is the significance of monoclonal gammopathy of undetermined significance? Clin. Med. (Northfield. Il. 2018.
12.
Bast EJEG, Van Camp B, Boom SE, Jaspers FCA. Differentiation between benign and malignant monoclonal gammopathy by the presence of the J chain. Clin Exp Immunol. 1981;44:375–82.PubMedPubMedCentral
Metadata
Title
Monoclonal Gammopathy of Unclear Significance in a Child with Wiskott-Aldrich Syndrome: a Rare Occurrence
Authors
Rashmi Rikhi
Sagar Bhattad
Ankur Jindal
Biman Saikia
Ravinder Garg
Amit Rawat
Deepti Suri
Surjit Singh
Publication date
01-01-2019
Publisher
Springer US
Published in
Journal of Clinical Immunology / Issue 1/2019
Print ISSN: 0271-9142
Electronic ISSN: 1573-2592
DOI
https://doi.org/10.1007/s10875-018-0585-9

Other articles of this Issue 1/2019

Journal of Clinical Immunology 1/2019 Go to the issue

Original Article

Progressive Multifocal Leukoencephalopathy in Primary Immunodeficiencies

Letter to Editor

MonoMAC Syndrome Caused by a Novel GATA2 Mutation Successfully Treated by Allogeneic Hematopoietic Stem Cell Transplantation

Original Article

A Novel Missense LIG4 Mutation in a Patient With a Phenotype Mimicking Behçet’s Disease

Original Article

Differing Performance of the Warning Signs for Immunodeficiency in the Diagnosis of Pediatric Versus Adult Patients in a Two-Center Tertiary Referral Population

Original Article

Outcomes for Nitazoxanide Treatment in a Case Series of Patients with Primary Immunodeficiencies and Rubella Virus-Associated Granuloma

Original Article

Autoimmunity and Inflammation in CVID: a Possible Crosstalk between Immune Activation, Gut Microbiota, and Epigenetic Modifications
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits